30679640|t|Off-target based drug repurposing opportunities for tivantinib in acute myeloid leukemia.
30679640|a|GSK3alpha has been identified as a new target in the treatment of acute myeloid leukemia (AML). However, most GSK3 inhibitors lack specificity for GSK3alpha over GSK3beta and other kinases. We have previously shown in lung cancer cells that GSK3alpha and to a lesser extent GSK3beta are inhibited by the advanced clinical candidate tivantinib (ARQ197), which was designed as a MET inhibitor. Thus, we hypothesized that tivantinib would be an effective therapy for the treatment of AML. Here, we show that tivantinib has potent anticancer activity across several AML cell lines and primary patient cells. Tivantinib strongly induced apoptosis, differentiation and G2/M cell cycle arrest and caused less undesirable stabilization of beta-catenin compared to the pan-GSK3 inhibitor LiCl. Subsequent drug combination studies identified the BCL-2 inhibitor ABT-199 to synergize with tivantinib while cytarabine combination with tivantinib was antagonistic. Interestingly, the addition of ABT-199 to tivantinib completely abrogated tivantinib induced beta-catenin stabilization. Tivantinib alone, or in combination with ABT-199, downregulated anti-apoptotic MCL-1 and BCL-XL levels, which likely contribute to the observed synergy. Importantly, tivantinib as single agent or in combination with ABT-199 significantly inhibited the colony forming capacity of primary patient AML bone marrow mononuclear cells. In summary, tivantinib is a novel GSK3alpha/beta inhibitor that potently kills AML cells and tivantinib single agent or combination therapy with ABT-199 may represent attractive new therapeutic opportunities for AML.
30679640	52	62	tivantinib	Chemical	MESH:C551661
30679640	66	88	acute myeloid leukemia	Disease	MESH:D015470
30679640	90	99	GSK3alpha	Gene	2931
30679640	156	178	acute myeloid leukemia	Disease	MESH:D015470
30679640	180	183	AML	Disease	MESH:D015470
30679640	237	246	GSK3alpha	Gene	2931
30679640	252	260	GSK3beta	Gene	2932
30679640	308	319	lung cancer	Disease	MESH:D008175
30679640	331	340	GSK3alpha	Gene	2931
30679640	364	372	GSK3beta	Gene	2932
30679640	422	432	tivantinib	Chemical	MESH:C551661
30679640	434	440	ARQ197	Chemical	MESH:C551661
30679640	467	470	MET	Gene	79811
30679640	509	519	tivantinib	Chemical	MESH:C551661
30679640	571	574	AML	Disease	MESH:D015470
30679640	595	605	tivantinib	Chemical	MESH:C551661
30679640	652	655	AML	Disease	MESH:D015470
30679640	679	686	patient	Species	9606
30679640	694	704	Tivantinib	Chemical	MESH:C551661
30679640	821	833	beta-catenin	Gene	1499
30679640	869	873	LiCl	Chemical	MESH:D018021
30679640	926	931	BCL-2	Gene	596
30679640	942	949	ABT-199	Chemical	MESH:C579720
30679640	968	978	tivantinib	Chemical	MESH:C551661
30679640	985	995	cytarabine	Chemical	MESH:D003561
30679640	1013	1023	tivantinib	Chemical	MESH:C551661
30679640	1073	1080	ABT-199	Chemical	MESH:C579720
30679640	1084	1094	tivantinib	Chemical	MESH:C551661
30679640	1116	1126	tivantinib	Chemical	MESH:C551661
30679640	1135	1147	beta-catenin	Gene	1499
30679640	1163	1173	Tivantinib	Chemical	MESH:C551661
30679640	1204	1211	ABT-199	Chemical	MESH:C579720
30679640	1242	1247	MCL-1	Gene	4170
30679640	1252	1258	BCL-XL	Gene	598
30679640	1329	1339	tivantinib	Chemical	MESH:C551661
30679640	1379	1386	ABT-199	Chemical	MESH:C579720
30679640	1450	1457	patient	Species	9606
30679640	1458	1461	AML	Disease	MESH:D015470
30679640	1505	1515	tivantinib	Chemical	MESH:C551661
30679640	1527	1541	GSK3alpha/beta	Gene	2931
30679640	1572	1575	AML	Disease	MESH:D015470
30679640	1586	1596	tivantinib	Chemical	MESH:C551661
30679640	1638	1645	ABT-199	Chemical	MESH:C579720
30679640	1705	1708	AML	Disease	MESH:D015470
30679640	Negative_Correlation	MESH:C551661	MESH:C579720
30679640	Negative_Correlation	MESH:C579720	4170
30679640	Negative_Correlation	MESH:C551661	79811
30679640	Association	MESH:D015470	2931
30679640	Negative_Correlation	MESH:C579720	598
30679640	Negative_Correlation	MESH:C579720	MESH:D015470
30679640	Negative_Correlation	MESH:C551661	4170
30679640	Positive_Correlation	MESH:C551661	1499
30679640	Negative_Correlation	MESH:C551661	MESH:D003561
30679640	Negative_Correlation	MESH:C551661	598
30679640	Negative_Correlation	MESH:C551661	2932
30679640	Negative_Correlation	MESH:C579720	1499
30679640	Negative_Correlation	MESH:C579720	596
30679640	Negative_Correlation	MESH:C551661	MESH:D015470
30679640	Negative_Correlation	MESH:C551661	MESH:D008175
30679640	Negative_Correlation	MESH:C551661	2931

